ViewTube

How can BRCA1 and BRCA2 mutations impact breast cancer risk? Who should consider genetic testing? Can BRCA mutations ...

We teach how to identify if you are at risk for the BRCA genetic mutation. If you carry this “breast cancer gene mutation” you are at ...

REUPLOADING TO FIX VIDEO ISSUE BRCA1 and BRCA2 Mutations & Cancer (Types of Cancer, and Who's Most At Risk) ...

The story of breast cancer survivor Billie Jo Maack and how the V Foundation is teaming up with the BRCA and Gray Foundations ...

Dr. Port discusses the BRCA Gene Mutation.

In her talk, Jessica Baglieri introduces the audience to BRCA1/BRCA2 genetic mutations, shares what it is like to receive a ...

Subscribe to The Doctors: http://bit.ly/SubscribeTheDrs LIKE us on Facebook: http://bit.ly/FacebookTheDoctors Follow us on ...

Here is what women should know about the newly-launched, user-friendly, at-home, BRCA genetic mutation test.

Access more!: https://www.dr2women.com What can be done to reduce your risk of getting breast cancer if you are at high risk or ...

What does carrying the BRCA 1 and 2 gene mutations mean for breast cancer patients? Which patients should consider being ...

Basser Center Genetic Counselor Jacquelyn Powers, MS, LCGC, discusses the basic of BRCA mutations in men and shares ...

In this video, Judith Balmaña addresses the role of the BRCA1 and BRCA2 proteins in cancer risk assessment, early detection ...

http://www.myJLI.com Life in the Balance: Jewish Perspectives on Everyday Medical Dilemmas A New Six Week Course by the ...

Panelists Adam M. Brufsky, MD, PhD; José Baselga, MD, PhD; Debu Tripathy, MD; Kimberly L. Blackwell, MD; and Carlos L.

PCRI's Alex asks Mark Scholz, MD, about genetic testing for men with advanced prostate cancer; specifically, BRCA testing which ...

In 2020, olaparib (Lynparza) and rucaparib (Rubraca) were FDA-approved for the treatment of men with castrate-resistant prostate ...

This video helps you understand cancer risk associated with BRCA mutations, shares the most up-to-date cancer screening and ...

The Clinical Potential of Novel Poly ADP-Ribose Polymerase Inhibitors for Improved Management of Epithelial Ovarian Cancer, ...

Expert oncologists consider the use of olaparib and bevacizumab as maintenance therapy in patients with BRCA1/2-mutated ...

Olaparib and Rucaparib were recently approved for the treatment of advanced prostate cancer in men with a BRCA mutation.